Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease (Q47942475)

7 February 2018

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease (English)

1 reference

7 February 2018

0 references

Joseph H Lee

5

0 references

author name string

Herve Rhinn

1

1 reference

7 February 2018

Ryousuke Fujita

2

1 reference

7 February 2018

Liang Qiang

3

1 reference

7 February 2018

Rong Cheng

4

1 reference

7 February 2018

Asa Abeliovich

6

1 reference

7 February 2018

language of work or name

English

0 references

publication date

24 July 2013

1 reference

7 February 2018

published in

Nature

1 reference

7 February 2018

volume

500

1 reference

7 February 2018

issue

7460

1 reference

7 February 2018

page(s)

45-50

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1038/nature12415

exact match

0 references

cites work

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

1 reference

12 December 2020

Enhanced amyloidogenic metabolism of the amyloid beta-protein precursor in the X11L-deficient mouse brain.

1 reference

12 December 2020

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

12 December 2020

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides

1 reference

12 December 2020

Cotrafficking of SV2 and synaptotagmin at the synapse.

1 reference

12 December 2020

In VivoAssessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-Life

1 reference

12 December 2020

Interactome mapping suggests new mechanistic details underlying Alzheimer's disease

1 reference

12 December 2020

The novel membrane protein TMEM59 modulates complex glycosylation, cell surface expression, and secretion of the amyloid precursor protein

1 reference

12 December 2020

A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging

1 reference

12 December 2020

Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target

1 reference

12 December 2020

Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia

1 reference

12 December 2020

The NCBI dbGaP database of genotypes and phenotypes

1 reference

12 December 2020

Housekeeping while brain's storming Validation of normalizing factors for gene expression studies in a murine model of traumatic brain injury

1 reference

12 December 2020

Regulatory impact factors: unraveling the transcriptional regulation of complex traits from expression data.

1 reference

12 December 2020

Concerted perturbation observed in a hub network in Alzheimer's disease

1 reference

12 December 2020

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study

1 reference

12 December 2020

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

1 reference

12 December 2020

Common genetic variation and performance on standardized cognitive tests

1 reference

12 December 2020

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

1 reference

12 December 2020

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

1 reference

12 December 2020

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model

1 reference

12 December 2020

A differential wiring analysis of expression data correctly identifies the gene containing the causal mutation.

1 reference

12 December 2020

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

1 reference

12 December 2020

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

1 reference

12 December 2020

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly

1 reference

12 December 2020

Genome-wide association of lipid-lowering response to statins in combined study populations

1 reference

12 December 2020

Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease

1 reference

12 December 2020

Patterns of brain activation in people at risk for Alzheimer's disease.

1 reference

12 December 2020

Apolipoprotein E: far more than a lipid transport protein

1 reference

12 December 2020

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

1 reference

12 December 2020

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

12 December 2020

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

1 reference

12 December 2020

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein receptor 2 and X11 alpha/beta mediate apolipoprotein E-induced endocytosis of amyloid-beta precursor protein and beta-secretase, leading to amyloid-beta production

1 reference

12 December 2020

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

1 reference

12 December 2020

Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease

1 reference

12 December 2020

Toward a remembrance of things past: deciphering Alzheimer disease.

1 reference

12 December 2020

Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks

1 reference

12 December 2020

Transcriptomic analysis of autistic brain reveals convergent molecular pathology

1 reference

12 December 2020

Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment

1 reference

12 December 2020

Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome

1 reference

12 December 2020

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

12 December 2020

Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease

1 reference

12 December 2020

BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production

1 reference

12 December 2020

Genetic control of human brain transcript expression in Alzheimer disease

1 reference

12 December 2020

Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons

1 reference

12 December 2020

A hundred years of Alzheimer's disease research

1 reference

12 December 2020

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

1 reference

12 December 2020

Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology

1 reference

12 December 2020

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

1 reference

12 December 2020

ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context

1 reference

12 December 2020

Fyn modulation of Dab1 effects on amyloid precursor protein and ApoE receptor 2 processing

1 reference

12 December 2020

Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease.

1 reference

12 December 2020

Apolipoprotein E and Alzheimer disease.

1 reference

12 December 2020

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

1 reference

12 December 2020

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers

1 reference

12 December 2020

Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/NATURE12415

1 reference

7 February 2018

Dimensions Publication ID

0 references

1 reference

7 February 2018